Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
2.780
-0.560 (-16.77%)
Aug 21, 2025, 4:00 PM - Market closed

Liminatus Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22
728075349
Market Cap Growth
-14.88%6.12%-78.38%-
Enterprise Value
9297--
Last Close Price
2.7811.2210.3310.12
PB Ratio
--4.14-4.78-32.30
Debt / Equity Ratio
--1.03-1.02-1.53
Quick Ratio
-0.000.030.29
Current Ratio
-0.210.120.39
Return on Assets (ROA)
--54.41%-66.30%-
Return on Capital (ROIC)
--468.22%-101.31%-
Earnings Yield
-4.90%-4.43%-6.60%-0.84%
Buyback Yield / Dilution
74.62%-9.49%-188.25%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q